COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis
- PMID: 36562753
- DOI: 10.1136/gutjnl-2022-327799
COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis
Keywords: CIRRHOSIS; COVID-19.
Conflict of interest statement
Competing interests: BVJ received institutional research support from BMS, Exelixis, Exact Sciences, GSK, Glycotest, Inc, H3B biosciences, Viking therapeutics. DEK received institutional research support from Gilead Sciences, Glycotest, Astra Zeneca, Bayer and Exact Sciences. None of the other authors have personal or financial conflicts of interests to declare in relation to this publication
Comment on
-
Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.Gut. 2021 Oct;70(10):1925-1932. doi: 10.1136/gutjnl-2020-323800. Epub 2021 Jan 29. Gut. 2021. PMID: 33514597 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical